Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.

@article{Marr2008PrimaryAP,
  title={Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.},
  author={Kieren a. Marr},
  journal={Current opinion in infectious diseases},
  year={2008},
  volume={21 4},
  pages={409-14}
}
PURPOSE OF REVIEW Infectious complications after hematopoietic stem cell transplant, especially those caused by fungi, contribute to poor outcomes. Availability of new antifungal drugs has led to creative attempts to prevent infections caused by both yeasts and molds with new antifungal prophylaxis strategies; these studies will be reviewed. RECENT FINDINGS Trials evaluating mold-active azoles, posaconazole and voriconazole, demonstrate that invasive aspergillosis infections can be prevented… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Similar Papers

Loading similar papers…